Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 18 of 23
Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours
NCT03086967
Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT01681875
Does Oral Micronized Progesterone Shorten Time of Symptoms From Concussion
NCT01809639
Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?
NCT02728999
Persistent Pain After CS Delivery
NCT01996592
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
NCT01766219
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis
NCT02397629
Atrial Pressure Electrophysiology Pilot Study
NCT01845974
Adductor Canal Block for Medial Compartment Knee Arthroplasty
NCT01818531
Feasibility of Upright Bed Position in ARDS Patients
NCT02160561
A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU
NCT02003053
Foley Catheter for Induction of Labor
NCT02044458
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
NCT01835041
Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study
NCT01848548
Macronutrient Effects on Alzheimer's Disease (MEAL-2)
NCT02463084
Parents and Children Together Preventing Diabetes (PACT PD)
NCT01819493
Pelvic CT Imaging in Blunt Abdominal Trauma
NCT01828749
Evidence-Based Tobacco Cessation Strategies in Patients With Cancer
NCT02211196
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
NCT02040116
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
NCT01719562
Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy
NCT01596634
Evaluation of Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
NCT01929928
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01768897
Almased Multi-Center Diabetes Intervention Trial
NCT01702012
Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain
NCT01953276
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon Fractures
NCT02051933
Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer
NCT02589938
Using Ultrasound to Study Respiratory Muscle Function in Critically Ill Patients
NCT03139695
Muscle Ultrasound Signifies Condition Upgrade Leading Approach to Recovery
NCT02014285
Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT
NCT01724619
The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients
NCT01794338
Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
NCT01519596
The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery
NCT02684851
Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain
NCT01665521
Ankle Fracture vs Ankle Fracture-Dislocation
NCT02198768
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
NCT01535040
RITHM - Resonance Imaging Trial for Heart Biomarkers in Adolescent/Young (AYA) Cancer Survivors
NCT01719094
MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters
NCT01692561
Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy
NCT01779739
Stereotactic Radiation to Decrease Pancreatic Secretions
NCT01656486
Dietary Nitrate Supplements and Ischemic Stroke Recovery
NCT02838901
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer
NCT01656044
Effectiveness of Web-based Teaching to Traditional Patient Education in the Use of Injectable Fertility Medications
NCT02420964
Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates
NCT01630122
Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures
NCT01516684
Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery
NCT01593657
Mild Traumatic Brain Injury Registry
NCT01688869
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
NCT01657383
Remote Ischemic Preconditioning Mechanism Study
NCT01541436
Cooperative Lifestyle Programs (CLIP-II)
NCT01547182
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.